Reaction
Acute Prerenal Failure reporting signals
As of the last recalculation, Acute Prerenal Failure appears in 1,156 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is ENALAPRIL MALEATE (PRR 27.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Enalapril Maleate | 36 | 27.0 | 27.0 |
| Cimetidine | 14 | 26.5 | 26.5 |
| Metolazone | 16 | 26.0 | 26.0 |
| Acetylcysteine | 11 | 21.2 | 21.2 |
| Digoxin | 73 | 19.5 | 19.5 |
| Amlodipine Besylate And Benazepril Hydrochloride | 9 | 17.7 | 17.7 |
| Torsemide | 31 | 17.3 | 17.3 |
| Salmeterol Xinafoate | 8 | 16.8 | 16.8 |
| Spironolactone | 103 | 14.4 | 14.4 |
| Gemfibrozil | 12 | 14.4 | 14.4 |
| Tolterodine Tartrate | 7 | 14.1 | 14.1 |
| Metformin Hcl | 37 | 12.4 | 12.4 |
| Lisinopril And Hydrochlorothiazide | 7 | 12.4 | 12.4 |
| Human Insulin | 8 | 11.6 | 11.6 |
| Lisinopril And Hydrochlorothiazide Tablets | 5 | 11.5 | 11.5 |
| Eplerenone | 8 | 11.3 | 11.3 |
| Felodipine Extended-Release Tablets | 7 | 11.1 | 11.1 |
| Felodipine | 7 | 11.1 | 11.1 |
| Ezetimibe And Simvastatin | 9 | 10.7 | 10.7 |
| Gefitinib | 5 | 10.0 | 10.0 |
| Orlistat | 13 | 9.1 | 9.1 |
| Panitumumab | 7 | 8.1 | 8.1 |
| Erlotinib | 4 | 7.5 | 7.5 |
| Irinotecan Hydrochloride | 5 | 7.0 | 7.0 |
| Deferasirox | 10 | 6.8 | 6.8 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 4 | 6.5 | 6.5 |
| Erlotinib Hydrochloride | 4 | 5.8 | 5.8 |
| Cetuximab | 9 | 5.2 | 5.2 |